JMJair de Jesus Mari
Jair de Jesus Mari
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jair de Jesus Mari has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Alan Breier
Chief Medical Officer, Eli Lilly, Indianapolis, US. Alan_Breier/AM
2 shared publicationsAnna Maria Costa
1 shared publication- Eduardo Pondé de Sena
Universidade Federal da Bahia, Brasil
1 shared publication Matthew Hotopf
1 shared publication- Mauricio Silva de Lima
US Medical Affairs, Genentech, 1 DNA Way, South San Francisco, California, USA, 94080-4990
1 shared publication Maurício Silva de Lima
Medical Director, Eli Lilly Brazil; Federal University of Pelotas and Catholic University of Pelotas, Pelotas, Brazil
1 shared publication
Latest Publications
- 12 February 2007
- Published by Cambridge University Press (CUP) in Progress in Neurotherapeutics and Neuropsychopharmacology
- Vol. 2 (1) , 239-250
Can Quality of Life be Improved in Schizophrenia? Results From A Pragmatic, Randomized, Controlled Trial Comparing Olanzapine with First Generation Antipsychotics
- 12 February 2007
- Published by Cambridge University Press (CUP) in Progress in Neurotherapeutics and Neuropsychopharmacology
- Vol. 2 (1) , 239-250
Can Quality of Life be Improved in Schizophrenia? Results From A Pragmatic, Randomized, Controlled Trial Comparing Olanzapine with First Generation Antipsychotics
- 15 July 2005
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 66 (7) , 831-838
Quality of Life in Schizophrenia
- 15 July 2005
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 66 (7) , 831-838
Quality of Life in Schizophrenia